BANK OF AMERICA CORP /DE/
BankPosition in ADPT — Adaptive Biotechnologies Corp
CIK 70858
CHARLOTTE, NC
Position in ADPT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$17,043,486
+$3,949,632 QoQ
Shares Held
1,227,917
+52.3% QoQ
Ownership
0.767%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91.45096940591262.ToString("F0")%
Shared 0.ToString("F0")%
None 8.549030594087386.ToString("F0")%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Derivatives in ADPT
reported options exposure · as of Jun 30, 2020CallValue
$140,302
CallShares
2,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $6,863,803,811 across 34 Diagnostics & Research names. ADPT ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,533,403 | $2,719,833,571 | |
| 2 | DHR |
Danaher Corp /De/
|
6,252,116 | $1,185,401,190 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,752,902 | $343,533,731 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
488,017 | $274,211,867 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
207,286 | $261,429,102 | |
| 6 | WAT |
Waters Corp /De/
|
843,636 | $251,234,797 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,299,122 | $221,552,262 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,135,027 | $195,792,156 |
All Filings in ADPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,043,486 | 1,227,917 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $13,093,854 | 806,272 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $23,906,062 | 1,597,999 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $21,636,003 | 1,857,168 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,933,636 | 1,471,553 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,444,770 | 240,996 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,989,149 | 779,131 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,131,158 | 1,141,204 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,660,441 | 517,272 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $484,206 | 98,818 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,282,796 | 235,376 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $885,877 | 132,024 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,930,892 | 445,175 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,079,712 | 141,324 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,191,722 | 167,377 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,380,758 | 170,675 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,907,510 | 209,475 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,534,834 | 232,888 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $6,398,545 | 188,248 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,049,459 | 197,001 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $5,836,529 | 144,971 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $8,913,786 | 150,749 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $7,847,905 | 161,380 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,412,941 | 173,893 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $140,302 | 2,900 | Call | Defined | 2020-08-14 | |
| 2020-03-31 | $3,722,574 | 134,002 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||